Findings

What do systematic reviews say?

75 questions · 112 findings · 2 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 23 · 20.5%GRADE not reported 6 · 5.4%Very low 15 · 13.4%Low 9 · 8%Moderate 42 · 37.5%High 17 · 15.2%

BoNT‐A vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A vs placebo/no treatment

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Moderate

BoNT‐A vs placebo/no treatment

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Moderate

BoNT‐A vs placebo/no treatment

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

BoNT‐A vs placebo/no treatment

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
High

BoNT‐A vs placebo/no treatment

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
High

BoNT‐A/OT vs OT only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 84 participants
High

BoNT‐A/OT vs OT only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 69 participants
High

BoNT‐A/OT vs OT only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs BoNT‐A only

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
High

BoNT‐A/OT vs BoNT‐A only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Moderate